In the 12 mg group, every participant lost at least 5 percent, 93 percent lost at least 10 percent, and 83 percent lost at least 15 percent
We do not start therapy if you are pregnant, planning pregnancy, or have a personal/family history of medullary thyroid carcinoma (MTC) or MEN2
If weight management is your priority and you have metabolic risk factors, discussing evidence-based options with a qualified provider is essential
Your doctor will review your health and medical history to make sure ompounded tirzepatide is a viable option for you
Decreased appetite and weight loss: As Ozempic slows gastric emptying, a person may feel satiated quickly (early satiety) or even lose their appetite entirely
Injection site reactions are a common side effect of Wegovy (affecting up to 1 in 10 people)